University of Kansas Neuromuscular Research Division
Improving the lives of people suffering from neuromuscular diseases through research.
Welcome to the University of Kansas Neuromuscular Research Division (KU NMRD). The neuromuscular division of the neurology department has particularly strong research programs in neuromuscular research, clinical care and education. The KU neuromuscular division, led by Dr. Mazen M. Dimachkie, has active NIH-sponsored studies in a variety of neuromuscular diseases and is an active site in national consortia including the Western ALS consortium, Northeast ALS consortium, ALS Research Group, and Muscle Study Group. These disorders include:
- Motor neuron disease: amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease), primary lateral sclerosis (PLS), progressive muscular atrophy (PMA), spinal muscular atrophy (SMA)
- Neuropathies: diabetic neuropathy, cryptogenic sensory neuropathy (CSPN), Guillain-Barre syndrome, chronic inflammatory demyelinating neuropathy (CIDP), Charcot-Marie-Tooth (CMT) disease, transthyretin amyloidosis
- Muscle disorders: polymyositis, inclusion body myositis, dermatomyositis, necrotizing myopathy (including SANAM), Duchenne muscular dystrophy, myotonic dystrophy, facioscapulohumeral muscular dystrophy, Pompe disease
- Neuromuscular junction disorders: myasthenia gravis and the Lambert-Eaton Myasthenic Syndrome.
We are delighted to welcome you to the number one neuromuscular research clinical trials unit in North America. This is the result of our intense and concerted focus and collaboration locally, nationally and internationally on a wide variety of neuromuscular research studies. Our goals are to better understand the natural history of disease, improve knowledge of disease biomarkers, and to translate research advances into improved diagnoses, care, and educational resources for neuromuscular patients. Our approach will ultimately lead to improving the lives of people suffering from neuromuscular diseases.